nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—ABCC5—Mercaptopurine—Crohn's disease	0.5	0.552	CbGbCtD
Sulfinpyrazone—ABCC4—Mercaptopurine—Crohn's disease	0.24	0.265	CbGbCtD
Sulfinpyrazone—ABCC2—Sulfasalazine—Crohn's disease	0.116	0.129	CbGbCtD
Sulfinpyrazone—ABCB1—Prednisone—Crohn's disease	0.0304	0.0335	CbGbCtD
Sulfinpyrazone—CYP3A4—Prednisone—Crohn's disease	0.0182	0.0201	CbGbCtD
Sulfinpyrazone—SLC22A12—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0103	0.214	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0103	0.214	CbGpPWpGaD
Sulfinpyrazone—ABCC2—bile—Crohn's disease	0.00936	0.201	CbGeAlD
Sulfinpyrazone—FABP2—epithelium—Crohn's disease	0.00706	0.152	CbGeAlD
Sulfinpyrazone—SLC22A12—digestive system—Crohn's disease	0.00537	0.116	CbGeAlD
Sulfinpyrazone—FABP2—digestive system—Crohn's disease	0.00537	0.116	CbGeAlD
Sulfinpyrazone—ABCC3—gall bladder—Crohn's disease	0.00325	0.07	CbGeAlD
Sulfinpyrazone—FABP2—lymph node—Crohn's disease	0.00307	0.066	CbGeAlD
Sulfinpyrazone—SLC22A12—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00207	0.0429	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00207	0.0429	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.00129	0.0267	CbGpPWpGaD
Sulfinpyrazone—ABCC3—digestive system—Crohn's disease	0.00128	0.0275	CbGeAlD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00119	0.0246	CbGpPWpGaD
Sulfinpyrazone—ABCC4—digestive system—Crohn's disease	0.00106	0.0227	CbGeAlD
Sulfinpyrazone—ABCC1—mammalian vulva—Crohn's disease	0.00103	0.0221	CbGeAlD
Sulfinpyrazone—ABCC2—digestive system—Crohn's disease	0.00102	0.022	CbGeAlD
Sulfinpyrazone—SLC22A12—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000939	0.0195	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000939	0.0195	CbGpPWpGaD
Sulfinpyrazone—ABCC5—lymph node—Crohn's disease	0.00087	0.0187	CbGeAlD
Sulfinpyrazone—CYP2B6—skin of body—Crohn's disease	0.00086	0.0185	CbGeAlD
Sulfinpyrazone—ABCC3—lymph node—Crohn's disease	0.000731	0.0157	CbGeAlD
Sulfinpyrazone—CYP2B6—lymphoid tissue—Crohn's disease	0.000696	0.015	CbGeAlD
Sulfinpyrazone—CYP2B6—digestive system—Crohn's disease	0.000688	0.0148	CbGeAlD
Sulfinpyrazone—CYP2C9—digestive system—Crohn's disease	0.000681	0.0147	CbGeAlD
Sulfinpyrazone—SLC22A12—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000662	0.0137	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000606	0.0126	CbGpPWpGaD
Sulfinpyrazone—ABCC4—lymph node—Crohn's disease	0.000603	0.013	CbGeAlD
Sulfinpyrazone—ABCC3—Recycling of bile acids and salts—ALB—Crohn's disease	0.000591	0.0123	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000585	0.0121	CbGpPWpGaD
Sulfinpyrazone—ABCC2—lymph node—Crohn's disease	0.000584	0.0126	CbGeAlD
Sulfinpyrazone—CYP3A4—digestive system—Crohn's disease	0.000519	0.0112	CbGeAlD
Sulfinpyrazone—ABCC1—lymph node—Crohn's disease	0.000514	0.0111	CbGeAlD
Sulfinpyrazone—ABCC4—Platelet degranulation—F5—Crohn's disease	0.000505	0.0105	CbGpPWpGaD
Sulfinpyrazone—ABCB1—epithelium—Crohn's disease	0.000483	0.0104	CbGeAlD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000481	0.00998	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000477	0.0099	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000477	0.0099	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000425	0.00882	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000425	0.00882	CbGpPWpGaD
Sulfinpyrazone—ABCB1—mammalian vulva—Crohn's disease	0.000419	0.00902	CbGeAlD
Sulfinpyrazone—ABCB1—lymphoid tissue—Crohn's disease	0.000372	0.00801	CbGeAlD
Sulfinpyrazone—ABCB1—digestive system—Crohn's disease	0.000368	0.00791	CbGeAlD
Sulfinpyrazone—ABCC1—S1P1 pathway—PTGS2—Crohn's disease	0.000353	0.00732	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000336	0.00697	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000331	0.00686	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000309	0.00641	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.0003	0.00622	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000297	0.00616	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Carbohydrate metabolism—GCKR—Crohn's disease	0.000272	0.00563	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000269	0.00558	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000267	0.00554	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000265	0.00549	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000224	0.00465	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000211	0.00437	CbGpPWpGaD
Sulfinpyrazone—ABCB1—lymph node—Crohn's disease	0.00021	0.00452	CbGeAlD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000195	0.00405	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000195	0.00405	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000178	0.00369	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000163	0.00338	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—ALB—Crohn's disease	0.000153	0.00318	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000151	0.00314	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000148	0.00307	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—Crohn's disease	0.000146	0.00303	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000144	0.00299	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000144	0.00299	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	0.000143	0.00297	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.00014	0.00291	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00014	0.00289	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000138	0.00285	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000135	0.00281	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000135	0.00281	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.000134	0.00279	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.00013	0.0027	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.00013	0.00269	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000122	0.00252	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	0.000121	0.00252	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000119	0.00246	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000118	0.00245	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—F5—Crohn's disease	0.000115	0.0024	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000114	0.00237	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000114	0.00237	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000113	0.00234	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000113	0.00234	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—RSPO3—Crohn's disease	0.000112	0.00233	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00011	0.00229	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PLA2G4F—Crohn's disease	0.000108	0.00223	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000107	0.00222	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—SEL1L—Crohn's disease	0.000106	0.00221	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000106	0.0022	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000105	0.00217	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000101	0.0021	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	9.88e-05	0.00205	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—LTF—Crohn's disease	9.55e-05	0.00198	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—ALB—Crohn's disease	9.54e-05	0.00198	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.54e-05	0.00198	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL10—Crohn's disease	9.53e-05	0.00198	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	9.41e-05	0.00195	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.24e-05	0.00192	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—MTMR3—Crohn's disease	9.15e-05	0.0019	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.97e-05	0.00186	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.89e-05	0.00184	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.65e-05	0.0018	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	8.49e-05	0.00176	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.43e-05	0.00175	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.04e-05	0.00167	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.95e-05	0.00165	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PLA2G4F—Crohn's disease	7.93e-05	0.00164	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—GCKR—Crohn's disease	7.69e-05	0.0016	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.62e-05	0.00158	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.24e-05	0.0015	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—FADS1—Crohn's disease	7.13e-05	0.00148	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.11e-05	0.00147	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—ITGA4—Crohn's disease	7.1e-05	0.00147	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.03e-05	0.00146	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IL3—Crohn's disease	6.92e-05	0.00144	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—ALB—Crohn's disease	6.8e-05	0.00141	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—SLC11A1—Crohn's disease	6.8e-05	0.00141	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—MTMR3—Crohn's disease	6.74e-05	0.0014	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—RASGRP1—Crohn's disease	6.7e-05	0.00139	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GPX4—Crohn's disease	6.67e-05	0.00138	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	6.52e-05	0.00135	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—RSPO3—Crohn's disease	6.49e-05	0.00135	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.48e-05	0.00134	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—GCKR—Crohn's disease	6.44e-05	0.00134	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	6.32e-05	0.00131	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PLA2G4F—Crohn's disease	6.21e-05	0.00129	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.2e-05	0.00129	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SEL1L—Crohn's disease	6.15e-05	0.00128	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.98e-05	0.00124	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HSPA1B—Crohn's disease	5.83e-05	0.00121	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—RBX1—Crohn's disease	5.83e-05	0.00121	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IFNG—Crohn's disease	5.6e-05	0.00116	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—LTF—Crohn's disease	5.51e-05	0.00114	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.37e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.37e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—MTMR3—Crohn's disease	5.28e-05	0.0011	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.27e-05	0.00109	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—FADS1—Crohn's disease	5.25e-05	0.00109	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	5.21e-05	0.00108	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—UBE2D1—Crohn's disease	5.11e-05	0.00106	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.05e-05	0.00105	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL1B—Crohn's disease	5e-05	0.00104	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GPX4—Crohn's disease	4.92e-05	0.00102	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IL2RA—Crohn's disease	4.85e-05	0.00101	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—GCKR—Crohn's disease	4.75e-05	0.000985	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.73e-05	0.00098	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—GCKR—Crohn's disease	4.44e-05	0.000922	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—ALB—Crohn's disease	4.38e-05	0.000908	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—FADS1—Crohn's disease	4.12e-05	0.000854	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.11e-05	0.000852	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	4.01e-05	0.000831	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SLC11A1—Crohn's disease	3.93e-05	0.000815	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GPX4—Crohn's disease	3.85e-05	0.000799	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.85e-05	0.000798	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.78e-05	0.000784	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—GCKR—Crohn's disease	3.72e-05	0.000772	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—SMAD3—Crohn's disease	3.66e-05	0.000759	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—TNF—Crohn's disease	3.63e-05	0.000752	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—ALB—Crohn's disease	3.51e-05	0.000727	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—MTMR3—Crohn's disease	3.41e-05	0.000707	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.4e-05	0.000704	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	3.39e-05	0.000704	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—RBX1—Crohn's disease	3.37e-05	0.000699	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HSPA1B—Crohn's disease	3.37e-05	0.000699	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.34e-05	0.000693	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—JAK2—Crohn's disease	3.26e-05	0.000676	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	3.23e-05	0.00067	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	3.04e-05	0.00063	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.97e-05	0.000616	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.96e-05	0.000613	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—UBE2D1—Crohn's disease	2.95e-05	0.000613	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—MTMR3—Crohn's disease	2.89e-05	0.000598	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	2.76e-05	0.000573	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.66e-05	0.000552	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—FADS1—Crohn's disease	2.65e-05	0.000551	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.65e-05	0.00055	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.56e-05	0.000531	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.53e-05	0.000525	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—MTMR3—Crohn's disease	2.51e-05	0.000521	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GPX4—Crohn's disease	2.49e-05	0.000516	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—GCKR—Crohn's disease	2.4e-05	0.000498	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TYK2—Crohn's disease	2.39e-05	0.000495	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.35e-05	0.000487	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.33e-05	0.000483	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—JAK2—Crohn's disease	2.28e-05	0.000472	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—FADS1—Crohn's disease	2.25e-05	0.000466	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CD4—Crohn's disease	2.16e-05	0.000448	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PTGS2—Crohn's disease	2.14e-05	0.000444	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SMAD3—Crohn's disease	2.11e-05	0.000438	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GPX4—Crohn's disease	2.1e-05	0.000437	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—ALB—Crohn's disease	2.05e-05	0.000425	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—GCKR—Crohn's disease	2.03e-05	0.000422	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—FADS1—Crohn's disease	1.96e-05	0.000406	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GPX4—Crohn's disease	1.83e-05	0.00038	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—FADS1—Crohn's disease	1.83e-05	0.000379	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.82e-05	0.000378	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PTGS2—Crohn's disease	1.79e-05	0.000372	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.79e-05	0.000371	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—GCKR—Crohn's disease	1.77e-05	0.000367	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GPX4—Crohn's disease	1.71e-05	0.000355	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—STAT3—Crohn's disease	1.67e-05	0.000347	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—GCKR—Crohn's disease	1.65e-05	0.000343	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.55e-05	0.000321	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ALB—Crohn's disease	1.51e-05	0.000314	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.45e-05	0.000301	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TYK2—Crohn's disease	1.38e-05	0.000286	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTGS2—Crohn's disease	1.32e-05	0.000274	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—JAK2—Crohn's disease	1.32e-05	0.000273	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.27e-05	0.000264	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CD4—Crohn's disease	1.25e-05	0.000259	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTGS2—Crohn's disease	1.24e-05	0.000257	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—FADS1—Crohn's disease	1.21e-05	0.00025	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.2e-05	0.00025	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ALB—Crohn's disease	1.18e-05	0.000246	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.18e-05	0.000245	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IL6—Crohn's disease	1.17e-05	0.000242	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.13e-05	0.000234	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.09e-05	0.000226	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTGS2—Crohn's disease	1.04e-05	0.000215	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.03e-05	0.000215	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—STAT3—Crohn's disease	9.65e-06	0.0002	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ALB—Crohn's disease	7.64e-06	0.000159	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IL6—Crohn's disease	6.74e-06	0.00014	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTGS2—Crohn's disease	6.69e-06	0.000139	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ALB—Crohn's disease	6.47e-06	0.000134	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTGS2—Crohn's disease	5.66e-06	0.000117	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ALB—Crohn's disease	5.64e-06	0.000117	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ALB—Crohn's disease	5.27e-06	0.000109	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTGS2—Crohn's disease	4.93e-06	0.000102	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTGS2—Crohn's disease	4.61e-06	9.55e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ALB—Crohn's disease	3.47e-06	7.2e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.04e-06	6.3e-05	CbGpPWpGaD
